Overview

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.
Phase:
Phase 3
Details
Lead Sponsor:
University of California, San Francisco
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Chlorthalidone
Hydrochlorothiazide
Triamterene